GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Lukas Biomedical Inc (ROCO:6814) » Definitions » Margin of Safety % (DCF FCF Based)

Lukas Biomedical (ROCO:6814) Margin of Safety % (DCF FCF Based) : N/A (As of Apr. 27, 2025)


View and export this data going back to 2020. Start your Free Trial

What is Lukas Biomedical Margin of Safety % (DCF FCF Based)?

Margin of Safety % (DCF FCF Based) = (Intrinsic Value: DCF (FCF Based) - Current Price) / Intrinsic Value: DCF (FCF Based).

Note: Discounted FCF model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Lukas Biomedical's Predictability Rank is Not Rated. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF FCF Based) is not calculated.

Competitive Comparison of Lukas Biomedical's Margin of Safety % (DCF FCF Based)

For the Biotechnology subindustry, Lukas Biomedical's Margin of Safety % (DCF FCF Based), along with its competitors' market caps and Margin of Safety % (DCF FCF Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Lukas Biomedical's Margin of Safety % (DCF FCF Based) Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Lukas Biomedical's Margin of Safety % (DCF FCF Based) distribution charts can be found below:

* The bar in red indicates where Lukas Biomedical's Margin of Safety % (DCF FCF Based) falls into.


;
;

Lukas Biomedical Margin of Safety % (DCF FCF Based) Related Terms

Thank you for viewing the detailed overview of Lukas Biomedical's Margin of Safety % (DCF FCF Based) provided by GuruFocus.com. Please click on the following links to see related term pages.

Lukas Biomedical Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Lukas Biomedical Inc (ROCO:6814) » Definitions » Margin of Safety % (DCF FCF Based)
Comparable Companies
ROCO:3205 ROCO:6610 ROCO:6652 ROCO:3118 ROCO:4194 ROCO:4192 ROCO:6236 ROCO:7725 ROCO:6662 ROCO:4195 VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
N/A
Address
No. 14-16, Zhongxiao Road, 1st Floor, Banqiao District, New Taipei City, TWN, 220
Website
https://www.lukas-biomedical.com
Lukas Biomedical Inc. is engaged in researching and developing immunotherapy for cancer treatment technologies. The company's main business activities include developing immunocellular therapy, leasing and selling medical equipment, and selling biotech beauty products.

Lukas Biomedical Headlines

No Headlines